Pancreatin represents a critical category of digestive enzyme replacement therapies, containing a mixture of porcine-derived enzymes including proteases, amylases, and lipases. This therapeutic preparation… Read more
Pancreatin represents a critical category of digestive enzyme replacement therapies, containing a mixture of porcine-derived enzymes including proteases, amylases, and lipases. This therapeutic preparation is primarily utilized to treat exocrine pancreatic insufficiency, a condition arising from chronic pancreatitis, cystic fibrosis, or other disorders where the body fails to produce sufficient endogenous digestive enzymes. Laboratories rely on high-quality reference standards of Pancreatin API to facilitate rigorous quality control and batch release testing. By utilizing these reference materials, along with pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds, analytical chemists can perform precise impurity profiling and method validation. These compounds are essential for verifying the enzymatic activity, stability, and composition of pancreatic enzyme products, ensuring they meet the stringent regulatory requirements necessary for pharmaceutical development and patient safety.